Inflammatory biomarkers in airways of patients with severe asthma compared with non‐severe asthma

Background About 5–10% of patients with asthma suffer from poorly‐controlled disease despite corticosteroid (CS) therapy.

[1]  I. Adcock,et al.  Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma , 2008, Thorax.

[2]  I. Pavord,et al.  Increased sputum and bronchial biopsy IL-13 expression in severe asthma. , 2008, The Journal of allergy and clinical immunology.

[3]  H. Matsumoto,et al.  Comparison of gel contraction mediated by airway smooth muscle cells from patients with and without asthma , 2007, Thorax.

[4]  K. Schechtman,et al.  Epithelial cell proliferation contributes to airway remodeling in severe asthma. , 2007, American journal of respiratory and critical care medicine.

[5]  P. Chanez,et al.  Specificity of basement membrane thickening in severe asthma. , 2007, The Journal of allergy and clinical immunology.

[6]  D. Curran‐Everett,et al.  Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. , 2007, The Journal of allergy and clinical immunology.

[7]  I. Adcock,et al.  Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. , 2006, American journal of respiratory and critical care medicine.

[8]  A. Nicholson,et al.  Nature of airway inflammation and remodeling in chronic cough. , 2005, The Journal of allergy and clinical immunology.

[9]  C. Lemière,et al.  Differences in airway remodeling between subjects with severe and moderate asthma. , 2005, The Journal of allergy and clinical immunology.

[10]  K. Chung,et al.  Increase in airway neutrophils after oral but not inhaled corticosteroid therapy in mild asthma. , 2005, Respiratory medicine.

[11]  M. Aubier,et al.  Airway structural alterations selectively associated with severe asthma. , 2003, American journal of respiratory and critical care medicine.

[12]  K. Chung,et al.  Severe asthma: definition and mechanisms , 2001, Allergy.

[13]  S. Spector,et al.  Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. , 2000, American journal of respiratory and critical care medicine.

[14]  K. Chung,et al.  Neutrophilic inflammation in severe persistent asthma. , 1999, American journal of respiratory and critical care medicine.

[15]  S. Wenzel,et al.  Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. , 1999, American journal of respiratory and critical care medicine.

[16]  D. Postma,et al.  Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society. , 1999, The European respiratory journal.

[17]  S. Wenzel,et al.  Collagen deposition in large airways may not differentiate severe asthma from milder forms of the disease. , 1998, American journal of respiratory and critical care medicine.

[18]  I. Virtanen,et al.  Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. , 1997, American journal of respiratory and critical care medicine.

[19]  J. Wilson,et al.  The measurement of reticular basement membrane and submucosal collagen in the asthmatic airway , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[20]  M. Ebina,et al.  Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study. , 1993, The American review of respiratory disease.

[21]  T. Haahtela,et al.  A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. , 1992, The Journal of allergy and clinical immunology.

[22]  P. Howarth,et al.  Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. , 1992, The American review of respiratory disease.

[23]  S. Holgate,et al.  SUBEPITHELIAL FIBROSIS IN THE BRONCHI OF ASTHMATICS , 1989, The Lancet.